ovarian cancer and glutathione International Journal of Oncology Frontiers | Unveiling drug resistance
Frontiers Unveiling drug resistance pathways in high grade serous ovarian cancer(HGSOC): recent advances and future perspectives Glutathione Transferase P1: Potential Therapeutic Target in Ovarian Cancer Glutathione and Thioredoxin Antioxidant Pathways Synergize to Drive Cancer Initiation and Progression: Cancer Cell Transforming treatment paradigms: Focus on personalized medicine for highgrade serous ovarian cancer Kordowitzki 2025 CA: A Cancer Journal for Clinicians Wiley Online Library PDF) Glutathione Transferase P1: Potential Therapeutic Target in Ovarian Cancer
Pay in 4 interest-free payments of $5.73 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9




